Three new classes of ionic organoselenium
compounds containing
cationic benzimidazolium and imidazolium ring systems with selenocyanates
as counterions are described. The cyclization of N,N′-disubstituted
benzimidazolium and imidazolium bromides having N-(CH2)2-Br and N-(CH2)3-Br groups in the presence of potassium selenocyanate
(KSeCN) led to formation of the corresponding selenazolium selenocyanates
(21a, 21b, 22a, and 22b) and selenazinium selenocyanates (21c, 21d, 22c, and 22d). However, the open-chain
selenocyanates with additional selenocyanate counterions (21e, 21f, 22e, and 22f) were
formed from the N,N′-disubstituted benzimidazolium and imidazolium
bromides having N-(CH2)6-Br
groups. Mechanistic studies were carried out to understand the feasibility
of such cyclization processes in the presence of KSeCN. The compounds
were studied further for their potencies to catalytically reduce H2O2 in the presence of thiols. Interestingly, the
cyclic selenazolium (21a, 21b, 22a, and 22b) and selenazinium compounds (21c, 21d, 22c, and 22d) exhibited
significantly higher antioxidant activities than the corresponding
acyclic selenocyanates (21f, 22e, and 22f). Selected compounds (22d and 22e) were further evaluated for their potencies in modulating the intracellular
level of reactive oxygen species (ROS) in a representative macrophage
cell line (RAW 264.7). Owing to the cationic nature of compounds,
they may target and scavenge mitochondrial ROS in the cellular medium.